Monobind Inc. is a global leader in IVD production and innovation. Founded in 1978, it has delivered 100M+ T4 tests to US and its portfolio of 120+ tests in AccuBind® ELISA & AccuLite® CLIA for; Thyroid, Neonatal & Autoimmune Thyroid, Fertility, Prenatal, Steroid, Growth, Cancer & Cardiac Markers, Diabetes, Infectious Disease, Allergy & Anemia. With robust R&D, state-of-the-art automation, FDA/ GMP/ ISO 13485/ CE Mark, Monobind sets standards of excellence reaching 115+ countries.